STEPHEN BODI: Open Payments
NPI 1548225063 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 59 payments from 21 companies in 2025. Trend: 2023 $2,022 · 2024 $2,038 · 2025 $1,275
Food & beverage: $1,250Entertainment: $25
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $238 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $167 |
| Novo Nordisk Inc | 5 | $122 |
| Amgen Inc. | 6 | $104 |
| Exact Sciences Corporation | 3 | $88 |
| Antares Pharma, Inc. | 4 | $77 |
| Abbott Laboratories | 1 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: Kerendia, FARXIGA, Ozempic, OTEZLA, The Cologuard Plus Collection Kit, XYOSTED, AFINION 2, REXULTI.
Industry payments across TX — which companies pay providers there.
